Alzheimer’s disease affects millions of individuals and their families, leaving many searching for answers and solutions.
With recent FDA approvals for breakthrough treatments like Leqembi and Donanemab, hope is finally on the horizon. These advancements promise to slow cognitive decline, giving residents and their loved ones more time together.
New therapies not only represent scientific progress but also provide a much-needed sense of hope for families navigating the uncertainties of Alzheimer’s disease, helping them plan for a future with greater clarity and optimism.
On Thursday, Nov. 7, The Kensington Sierra Madre will host a special event, “Ask a Neurologist,” with Dr. Kenneth K. Wogensen, a board-certified neurologist.
The event will share the latest Alzheimer’s treatments and offer guidance on navigating the disease with hope and support.
RSVP to learn about advancements in Alzheimer’s and dementia care and get all your questions answered in an enlightening Q&A session.
Our promise is to love and care for your family as we do our own.
New hope: Leqembi and Donanemab
In the face of a devastating disease like Alzheimer’s, new treatments such as Leqembi and Donanemab are offering a renewed sense of optimism.
Leqembi
Leqembi was approved by the FDA in 2023 and is a groundbreaking treatment aimed at targeting amyloid plaques in the brain—one of the key drivers of Alzheimer’s.
By removing these plaques, Leqembi helps slow the progression of cognitive decline, particularly for those in the early stages of the disease.
For many families, this drug represents a vital breakthrough. It offers the chance to preserve cognitive function for longer, allowing for meaningful connections with their loved ones.
Donanemab
Donanemab, approved in 2024, is another treatment that works similarly to Leqembi by reducing amyloid plaques in the brain.
Clinical trials have shown that Donanemab can slow the progression of Alzheimer’s by up to 35% in residents with early-stage Alzheimer’s.
This significant reduction in cognitive decline means more quality time for families and caregivers to support their loved ones through this challenging journey.
Both of these treatments signify a new era in Alzheimer’s care, focusing on slowing the disease rather than simply managing symptoms.
Dr. Wogensen will explain how these medications work and who may benefit most from them during the upcoming event.
Dr. Kenneth K. Wogensen: A trusted voice in Alzheimer’s care
Dr. Wogensen will provide attendees with valuable insights into these innovative drugs during our event.
With a background in treating dementia and Alzheimer’s and serving as the Director of the Stroke Program at Arcadia Methodist Hospital, Dr. Wogensen brings decades of experience to the conversation.
His expertise extends beyond Alzheimer’s treatment, as he also specializes in managing neurological conditions like vertigo, myasthenia gravis, and seizures.
Dr. Wogensen also uses cutting-edge diagnostic tools like electromyography and electroencephalography to evaluate brain and nerve function.
During the Q&A session, attendees will have the chance to ask Dr. Wogensen questions, making it a valuable opportunity to learn more about the specifics of Leqembi, Donanemab, and other late-stage clinical trials that are shaping the future of Alzheimer’s treatment.
Comprehensive care at The Kensington Sierra Madre
While advances in medical treatments are exciting, Alzheimer’s care requires more than medication. The Kensington Sierra Madre offers a holistic approach to caring for individuals with Alzheimer’s and dementia.
Our dedicated team provides round-the-clock support, ensuring each resident receives personalized care.
Families can take comfort in knowing that their loved ones have access to on-site physical, speech, and occupational therapy, which helps residents maintain as much independence as possible.
Enriching lives beyond medical care
In addition to expert medical care, The Kensington Sierra Madre is committed to enriching the lives of its residents through live music events, social activities, and wellness programs.
Life-enrichment activities like these are vital for maintaining cognitive function and emotional well-being.
Our community ensures that residents feel supported and connected, which is especially important for individuals navigating Alzheimer’s.
A supportive environment for families
Alzheimer’s is not only a challenging diagnosis for seniors but also for their families.
The Kensington Sierra Madre understands the emotional toll that Alzheimer’s can take on caregivers and loved ones.
That’s why we offer resources such as educational events, like the upcoming Ask a Neurologist session with Dr. Wogensen, and ongoing support for caregivers.
The Kensington Sierra Madre aims to empower families to make informed decisions about their loved one’s care by creating a space for open discussion and providing up-to-date information about the latest treatments.
Our team members pride themselves on being compassionate, knowledgeable, and dedicated to providing the highest standard of care.
Families can expect consistent communication and support throughout their loved one’s journey, with the assurance that their needs will be met with respect and dignity.
Looking forward: Leqembi and Donanemab
The FDA approvals of Leqembi and Donanemab represent significant milestones in Alzheimer’s treatment, giving seniors and their families new hope for slowing the disease’s progression.
While not cures, these drugs offer more time to make memories, enjoy shared experiences, and live fully.
For those living with Alzheimer’s, every day is precious, and these treatments offer the possibility of preserving those days for longer.
If you’re considering these treatment options for your loved one, The Kensington Sierra Madre and its knowledgeable team can offer support through the decision-making process.
Compassionate care at The Kensington Sierra Madre
At The Kensington Sierra Madre, compassionate care is at the heart of everything we do.
Whether through expert medical treatment, engaging activities, or holistic therapies, our team is committed to ensuring that residents with Alzheimer’s receive the care they deserve.
With the latest advances in Alzheimer’s treatments like Leqembi and Donanemab, there’s renewed hope for families facing this challenging diagnosis.
Our upcoming event with Dr. Kenneth K. Wogensen is a great opportunity to learn more about these new treatments and how they can positively impact the lives of those with Alzheimer’s.
Join us on Nov. 7, from 6 p.m. to 7 p.m. PST, for an informative discussion and a Q&A session with Dr. Wogensen.
Together, we can navigate the future of Alzheimer’s treatment with hope and compassion.
Contact The Kensington Sierra Madre today to explore how we can provide the care and support your family needs through every stage of the Alzheimer’s journey.